pHD-mW-attPCC-FRT (pTL717)
(Plasmid
#115158)
-
PurposeVector for generating dsDNA donors for HDR. Contains an attP-CC docking site, the visible GMR-white for identifying backbone incorporation flanked by FRT sites for FLP-mediated removal.
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 115158 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepHD-DsRed-attP
- Backbone size w/o insert (bp) 2796
- Total vector size (bp) 5974
-
Vector typeInsect Expression
-
Selectable markersmini-White
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namemW attP-CC FRT
-
SpeciesSynthetic
-
Insert Size (bp)3178
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site NdeI (not destroyed)
- 3′ cloning site SpeI (not destroyed)
- 5′ sequencing primer 5'-CGTAGCGCCGATGGTAGTGTG-3' / 5'-CTCGCATATCTGGCTCTAAGACTTC-3'
- 3′ sequencing primer 5'-CTACGCCCCCAACTGAGA-3' / 5'-ATGTTATCAGTATTTATTATGCA-3' (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Based on pHD-DsRed-attP vector (Gratz et al., Genetics, 2014; DOI: 10.1534/genetics.113.160713)
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pHD-mW-attPCC-FRT (pTL717) was a gift from Tobias Langenhan (Addgene plasmid # 115158 ; http://n2t.net/addgene:115158 ; RRID:Addgene_115158) -
For your References section:
Parallel Genomic Engineering of Two Drosophila Genes Using Orthogonal attB/attP Sites. Blanco-Redondo B, Langenhan T. G3 (Bethesda). 2018 Jul 31. pii: g3.118.200565. doi: 10.1534/g3.118.200565. 10.1534/g3.118.200565 PubMed 30065043